Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cultural Acceptability of Community Breast Cancer Risk

Recruiting
  • Breast Carcinoma
  • +2 more
  • Non-Interventional Study
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 31, 2023

Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

Not yet recruiting
  • Breast Cancer
  • +2 more
  • LS301-IT 0.025 mg/kg
  • +3 more
  • Scottsdale, Arizona
    Integro Theranostics Research Site #1
Jun 2, 2023

Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)

Completed
Has Results
  • Breast Cancer
  • Stage IV Breast Cancer
  • palliative surgery
  • +3 more
  • Mobile, Alabama
  • +376 more
Jan 6, 2023

Screening CEDM in Intermediate and High-Risk Patient Populations

Completed
  • Breast Cancer
  • Contrast Enhanced Digital Mammography
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 18, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Breast Cancer Trial in Scottsdale, Rochester (Hypofractionation)

Active, not recruiting
  • Breast Cancer
  • Hypofractionation
  • Scottsdale, Arizona
  • +1 more
Nov 11, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Breast Cancer Trial in United States (Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test)

Recruiting
  • Breast Cancer
  • Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
  • Daphne, Alabama
  • +104 more
Aug 17, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Prior to Decisions on Preventive Therapy Uptake,

Enrolling by invitation
  • Breast Cancer
  • Polygenic Risk Score
  • Scottsdale, Arizona
  • +4 more
Apr 5, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (Minnelide™Capsules)

Recruiting
  • Advanced Cancer
  • +9 more
  • Birmingham, Alabama
  • +6 more
Apr 4, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • PY314
  • Combination Therapy: PY314 + Pembrolizumab
  • Scottsdale, Arizona
  • +12 more
Mar 28, 2022

Breast Cancer Trial in Phoenix, Scottsdale, Rochester (Written educational brochure, Promotora interaction)

Active, not recruiting
  • Breast Cancer
  • Written educational brochure
  • Promotora interaction
  • Phoenix, Arizona
  • +2 more
Mar 22, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)

Active, not recruiting
Has Results
  • Breast Cancer
  • pegfilgrastim
  • +4 more
  • Anniston, Alabama
  • +541 more
Jan 19, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Breast Cancer, Lymph Node Mapping, Sentinel Lymph Node Biopsy Trial in Canada, United States (IC2000 and SPY-PHI, Tc-99m

Completed
  • Breast Cancer
  • +2 more
  • IC2000 and SPY-PHI
  • Tc-99m radioactive colloid and Gamma Probe
  • Scottsdale, Arizona
  • +6 more
Aug 17, 2021

Breast Cancer Trial in Belgium, France, United States (cyclophosphamide, Docetaxel, epirubicin HCl)

Completed
Has Results
  • Breast Cancer
  • Scottsdale, Arizona
  • +85 more
Apr 7, 2021

Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,

Terminated
  • Advanced Solid Tumors
  • +2 more
  • SY-1365 (Part 1)
  • +5 more
  • Birmingham, Alabama
  • +19 more
Mar 5, 2021